After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and ...

The cannabis-derived compound cannabidiol (CBD) is gaining traction as a treatment for a broad range of conditions, but it's ...

Medical cannabis is legal in the UK. This means that in some circumstances, specialist doctors may prescribe it to treat epilepsy. On this page, we talk about the different types of medical cannabis ...

Chicago, IL – March 12, 2025 – Zacks Equity Research shares Jazz Pharmaceuticals JAZZ as the Bull of the Day and The Boston Beer Company SAM as the Bear ...

Jazz Pharmaceuticals, a Zacks Rank #1 (Strong Buy), is a specialty biopharmaceutical company that identifies, develops, and ...

The stock market selloff heated up to start the week as Wall Street locked in profits amid the chaos caused by the tariff ...

Limited or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American ...

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe this is a good deal for Jazz.

In 2021, the company acquired GW Pharmaceuticals for $7.2bn, gaining the seizure medication Epidiolex (cannabidiol). In February 2024, it licensed a KRAS inhibitor programme from UK-based Redx Pharma ...

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Despite fluctuations, the bull run continued in 2025. However, U.S. stocks suffered a blow and the bull ...

It is one of the best cash rich stocks to invest in. On December 6, 2024, the company shared new research on Epidiolex (cannabidiol) at the American Epilepsy Society 2024 conference, showing its ...